alpha-aminopyridine has been researched along with Adenocarcinoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Imaoka, S; Korekane, H; Miyamoto, Y; Noura, S; Ohue, M; Sasaki, Y; Tsuji, S | 1 |
| Chao, YS; Chen, CN; Chen, JS; Chou, CH; Chu, SH; Wu, YH; Yang, MH | 1 |
| Fernandez-Lozano, C; Liñares-Blanco, J; Munteanu, CR; Pazos, A | 1 |
| Arai, Y; Hayashi, T; Kondo, A; Ninomiya, H; Shukuya, T; Suzuki, M; Takahashi, K; Takeshige, T; Ueda, S | 1 |
| Hochmair, MJ; Prosch, H; Schwab, S | 1 |
| Dong, L; Li, S; Xia, J; Zhang, J; Zhang, P; Zhang, X; Zhang, Y; Zhu, N | 1 |
| Liang, YC; Liu, Q; Liu, T; Shi, LL; Wu, G; Wu, HG; Xue, HJ | 1 |
| Herrera Loeza, SG; Kamande, JW; Moffitt, RA; Soper, SA; Tignanelli, CJ; Torphy, RJ; Yeh, JJ | 1 |
| He, DH; Hochwald, SN; Zajac-Kaye, M; Zhang, J | 1 |
| Kim, JE; Kim, W; Min, YH | 1 |
| Begum, J; Cerveira, J; Crockford, A; Cuomo, ME; Dewhurst, SM; Encheva, V; Grönroos, E; McGranahan, N; Patel, H; Purewal, S; Renshaw, MJ; Snijders, AP; Swanton, C; Zalmas, LP | 1 |
11 other study(ies) available for alpha-aminopyridine and Adenocarcinoma
| Article | Year |
|---|---|
Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis.
Topics: Acidic Glycosphingolipids; Adenocarcinoma; Aminopyridines; Biomarkers, Tumor; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Colonic Neoplasms; Fucose; Gangliosides; Gels; Glycoside Hydrolases; Humans; Oligosaccharides, Branched-Chain; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor.
Topics: Adenocarcinoma; Aminopyridines; Animals; Antibodies, Monoclonal; Benzamides; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Therapy, Combination; Immune Checkpoint Inhibitors; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid-Derived Suppressor Cells; Neoplasm Invasiveness; Neoplastic Processes; Programmed Cell Death 1 Receptor; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2022 |
Molecular docking and machine learning analysis of Abemaciclib in colon cancer.
Topics: Adenocarcinoma; Algorithms; Aminopyridines; Benzimidazoles; Cell Line, Tumor; Colonic Neoplasms; Databases, Protein; Drug Repositioning; Epistasis, Genetic; Fatty Acid-Binding Proteins; Gastrointestinal Hormones; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Machine Learning; Molecular Docking Simulation; Neoplasm Staging; Prognosis; Survival Analysis | 2020 |
Transformation from adenocarcinoma to squamous cell lung carcinoma with MET amplification after lorlatinib resistance: A case report.
Topics: Adenocarcinoma; Aminopyridines; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Lactams; Middle Aged; Pyrazoles | 2021 |
Complete remission of intrathecal metastases with lorlatinib therapy in a heavily pretreated ALK-positive lung cancer patient.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aminopyridines; Anaplastic Lymphoma Kinase; Female; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Middle Aged; Protein Kinase Inhibitors; Pyrazoles; Receptor Protein-Tyrosine Kinases; Spinal Cord Neoplasms | 2017 |
Long-term progression-free survival in an advanced lung adenocarcinoma patient harboring EZR-ROS1 rearrangement: a case report.
Topics: Adenocarcinoma; Aminopyridines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Crizotinib; Cytoskeletal Proteins; Gene Rearrangement; Humans; Lactams; Lactams, Macrocyclic; Lung Neoplasms; Male; Middle Aged; Oncogene Fusion; Pemetrexed; Progression-Free Survival; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Pyrazoles; Time Factors | 2018 |
Effects of PI3K inhibitor NVP-BKM120 on acquired resistance to gefitinib of human lung adenocarcinoma H1975 cells.
Topics: Adenocarcinoma; Aminopyridines; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gefitinib; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Matrix Metalloproteinase 9; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; RNA, Messenger; Vascular Endothelial Growth Factor A | 2013 |
Circulating tumor cells as a biomarker of response to treatment in patient-derived xenograft mouse models of pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aminopyridines; Animals; Antigens, Neoplasm; Biomarkers; Cell Adhesion Molecules; DNA Mutational Analysis; DNA Primers; Epithelial Cell Adhesion Molecule; Fluorescent Antibody Technique; Humans; Mice; Microfluidic Analytical Techniques; Morpholines; Neoplastic Cells, Circulating; Pancreatic Neoplasms; Statistics, Nonparametric | 2014 |
A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.
Topics: Adenocarcinoma; Aminopyridines; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hydroxamic Acids; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt | 2014 |
The Aurora kinase A inhibitor TC-A2317 disrupts mitotic progression and inhibits cancer cell proliferation.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Aminopyridines; Aurora Kinase A; Cell Cycle; Cell Proliferation; Enzyme Inhibitors; Humans; Lung Neoplasms; M Phase Cell Cycle Checkpoints; Mitosis | 2016 |
Cyclin D mediates tolerance of genome-doubling in cancers with functional p53.
Topics: Adenocarcinoma; Aminopyridines; Benzimidazoles; Cell Line, Tumor; Colorectal Neoplasms; Cyclin C; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cytochalasin B; Diploidy; Flow Cytometry; Gene Knockdown Techniques; Genes, p53; HCT116 Cells; Humans; Protein Kinase Inhibitors; Tetraploidy; Tumor Suppressor Protein p53 | 2017 |